Technology News and Research

RSS

Abraxis Health dedicates its new manufacturing facility in Phoenix

Abraxis Health, a fully-integrated personalized healthcare division of Abraxis BioScience, Inc., today announced the dedication of its new manufacturing facility in Phoenix, Arizona. The state of the art biopharma manufacturing plant represents a $70 million investment by LA-based Abraxis, and will create up to 200 high tech jobs.

5 Nov 2009

NewYork-Presbyterian Hospital establishes first co-generation plant in Manhattan

Demonstrating its commitment to clean energy and cost savings, NewYork-Presbyterian Hospital has switched on the first hospital-based co-generation plant in Manhattan. Located at 70th St. and York Ave. and unveiled today in a ribbon-cutting ceremony, the plant promises to reduce the emission of 20,000 tons of pollutants each year, the equivalent of taking 3,600 automobiles off the road, while adding millions of dollars in annual cost savings.

5 Nov 2009

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

The World Health Organization recently declared H1N1 swine flu a global pandemic, resulting in the creation of rigorous vaccination programs worldwide. Children are among those considered particularly susceptible to contracting swine flu and are viewed as a top priority in receiving this vaccine.

5 Nov 2009

NIH grant to develop a new method for rapidly screening blood samples for biomarkers

Dr. Jennifer Brodbelt, professor of chemistry and biochemistry at The University of Texas at Austin, has received a $734,068 grant from the National Institutes of Health (NIH) to develop a new method for rapidly screening blood samples for biomarkers.

5 Nov 2009

Amputees who use running-specific prosthetic legs have no performance advantage, say researchers

A study by six researchers, including a University of Colorado at Boulder associate professor and his former doctoral student, shows that amputees who use running-specific prosthetic legs have no performance advantage over counterparts who use their biological legs.

5 Nov 2009

Imagenetix awarded U.S. patent for its 1-TDC drug candidate to treat periodontal disease

Imagenetix, Inc., announced today the issuance of a new U.S. patent (No. 7,612,111). The patent provides intellectual property protection for Imagenetix's 1-TDC early stage drug candidate for the prevention and treatment of periodontal disease.

5 Nov 2009

Micro-injector may help rapid development of new generation of drugs

It's no bigger than a stamp packet but it has the potential to allow rapid development of a new generation of drugs and genetic engineering organisms, and to better control in-vitro fertilization.

5 Nov 2009

Pfizer and Flamel Technologies sign license agreement

Flamel Technologies today announced that Pfizer (NYSE:PFE) has exercised its option to license Flamel’s Medusa® technology for the development of a controlled release formulation of an already-marketed therapeutic protein.

5 Nov 2009

Echo Therapeutics commences its Symphony Transdermal Continuous Glucose Monitoring System clinical study

Echo Therapeutics, Inc., a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes.

5 Nov 2009

Cook Medical and AOPA partner to offer AAA screenings at AOPA Aviation Summit

Cook Medical is partnering with the Aircraft Owners and Pilots Association (AOPA) at this year’s AOPA Aviation Summit in Tampa, Fla. from November 5-7 to provide free abdominal aortic aneurysm (AAA) screenings to its attendees at high risk for AAA.

5 Nov 2009

Lethal new MRSA strain resists antibiotics, increases demand for Unotron’s disinfectable and washable keyboards

A deadly new strain of methicillin-resistant Staphylociccus auerus (MRSA) poses an alarming new threat, sparking demand for Unotron’s (www.unotron.com) medical grade, fully washable keyboards and mice that can be disinfected to mitigate the spread of germs. A study conducted by the Henry Ford Hospital reported the USA600 strain resists Vancomycin, a drug successfully used in the past to treat patients with MRSA.

5 Nov 2009

PEPFAR expands efforts to improve health services worldwide through use of mobile devices

Fierce Mobile reports on the recent announcement that PEPFAR is teaming up with the United Nations Foundation, Rockefeller Foundation and Vodafone Foundation to be a founding member of the mHealth Alliance, "a group seeking to bring health services to the most remote corners of the globe using mobile networks and technologies." U.S. Global AIDS Coordinator Eric Goosby announced the partnership during a keynote address last week at the inaugural mHealth Summit in Washington, D.C., according to the news service (Versel, 11/3).

4 Nov 2009

Alcatel-Lucent receives FDA clearance to market Alcatel-Lucent TeleHealth Manager in the US

Alcatel-Lucent today announced that the Alcatel-Lucent TeleHealth Manager, a secure and reliable remote patient monitoring solution, has been cleared by the U.S. Food and Drug Administration (FDA) for marketing in the United States.

4 Nov 2009

Automated temperature monitoring module for health care facilities

Patient Care Technology Systems (PCTS), a subsidiary of Consulier Engineering, Inc. (NASDAQ: CSLR), today announced the availability of its most advanced automated temperature monitoring module.

4 Nov 2009

Foamix' emollient foam platform awarded Mexican patent

Foamix Ltd., a leading developer of topical foams for dermatological and gynecological use, announced today that it has been awarded Mexican Patent Registration No. 268451 entitled "Cosmetic and Pharmaceutical Foam." The patent covers Foamix's vehicles, compositions and cosmetic and pharmaceutical uses thereof based on the company's Emollient Foam technology platform.

4 Nov 2009

MRG's new report on the European markets for small-joint reconstructive implants

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for small-joint reconstructive implants will double by 2014, reaching almost $360 million.

4 Nov 2009

Spray dryer strengthens PharmaForm's portfolio of bioavailability enhancement solutions

PharmaForm, a contract pharmaceutical development and manufacturing organization and a wholly owned subsidiary of Akela Pharma Inc. (TSX: AKL), today announced that it has added aqueous and solvent spray drying to its portfolio of bioavailability enhancement solutions.

4 Nov 2009

Spinal Modulation completes its $27.4 million Series C financing

Spinal Modulation, Inc. announced today the completion of its $27.4 million Series C financing. Johnson & Johnson Development Corporation (JJDC) joined existing major investors including DeNovo Ventures, ePlanet/DFJ, Kleiner Perkins Caufield & Byers, and MedVenture Associates in this financing. DFJ/InCube Ventures and Raffles Venture Partners are additional new investors.

4 Nov 2009

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has advanced to the RNAi therapeutic collaboration stage of its landmark alliance with Roche formed in 2007.

4 Nov 2009

AHDI and MTIA support healthcare reform package

As health information managers and professionals across the country celebrate the health information & technology industry this week, the Association for Health Care Documentation Integrity (AHDI) and the Medical Transcription Industry Association (MTIA) announced their support for a healthcare reform package that improves electronic health records (EHRs) as well as patient safety.

4 Nov 2009

Technology News and Research

Abraxis Health dedicates its new manufacturing facility in Phoenix

NewYork-Presbyterian Hospital establishes first co-generation plant in Manhattan

Phadia offers ImmunoCAP, a reliable test to accurately diagnose the severity of egg allergy

NIH grant to develop a new method for rapidly screening blood samples for biomarkers

Amputees who use running-specific prosthetic legs have no performance advantage, say researchers

Imagenetix awarded U.S. patent for its 1-TDC drug candidate to treat periodontal disease

Micro-injector may help rapid development of new generation of drugs

Pfizer and Flamel Technologies sign license agreement

Echo Therapeutics commences its Symphony Transdermal Continuous Glucose Monitoring System clinical study

Cook Medical and AOPA partner to offer AAA screenings at AOPA Aviation Summit

Lethal new MRSA strain resists antibiotics, increases demand for Unotron’s disinfectable and washable keyboards

PEPFAR expands efforts to improve health services worldwide through use of mobile devices

Alcatel-Lucent receives FDA clearance to market Alcatel-Lucent TeleHealth Manager in the US

Automated temperature monitoring module for health care facilities

Foamix' emollient foam platform awarded Mexican patent

MRG's new report on the European markets for small-joint reconstructive implants

Spray dryer strengthens PharmaForm's portfolio of bioavailability enhancement solutions

Spinal Modulation completes its $27.4 million Series C financing

Alnylam Pharmaceuticals and Roche team up to develop specific RNAi therapeutic products

AHDI and MTIA support healthcare reform package

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News